Although all these data identify a new MEK5/ERK5–lipid metabolism axis that promotes cancer growth, the molecular mechanisms underlying the role of ERK5 on cell metabolism in the tumor microenvironment (TME) remain to be investigated. This evidence concerns the gene MAP2K5 and cancer.